$ESPR insider trading

Over the last 12 months, Esperion Therapeutics insiders reported no purchases and 10 sales totaling $203K across SEC Form 4 filings.

$203K
10
8
0%
Side
$10K$100K$1.0Mno $Jun '26JulAug
Halladay Benjamin
Koenig Sheldon L.
Hoffman Robert E.
Shepard Jay
Fischer Seth H. Z.

All insider trades

Scroll the table sideways for price, value and marks.

Jul 13, 2026Hoffman Robert E.▽ Sale to issuer85,153-100%
Jul 13, 2026Shepard Jay▽ Sale to issuer164,472-100%
Jul 13, 2026Fischer Seth H. Z.▽ Sale to issuer141,023-100%
Jul 13, 2026THOMPSON JOHN CRAIG▽ Sale to issuer79,873-100%
Jul 13, 2026Harlow John B. Jr.▽ Sale to issuer424,536-100%
Jul 13, 2026Looker Benjamin▽ Sale to issuer667,524-100%
Jul 13, 2026Halladay Benjamin▽ Sale to issuer705,410-100%
Jul 13, 2026Koenig Sheldon L.▽ Sale to issuer2,121,094-100%
Jun 17, 2026Koenig Sheldon L.▼ Sale53,588$3.16$169K-2.5%
Jun 17, 2026Halladay Benjamin▼ Sale10,773$3.16$34K-1.5%

Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $ESPR feed.

ESPR Insider Trading — Form 4 Buys & Sells | alphai